SUBSCRIBE
SUBSCRIBE
News   FDA

Merck & Co., Inc. Vaccine Wins OK for Vaginal Cancer

September 15, 2008 | 
1 min read

WASHINGTON (Reuters) - U.S. health regulators have approved Merck and Co’s Gardasil vaccine to protect women against rare vaginal and vulvar cancers, the Food and Drug Administration said on Friday.

FDA Approvals
Merck & Co.
MORE ON THIS TOPIC
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Approvals
Ionis’ Tryngolza Becomes First FDA-Approved Therapy for Familial Chylomicronemia Syndrome
December 20, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Confirms Lilly’s GLP-1s Are Not in Shortage, Gives Compounders Grace Period
December 19, 2024
 · 
3 min read
 · 
Tristan Manalac
Pictured: 3D illustration of stem cells used for cell therapy
Cell therapy
Mesoblast Wins First Mesenchymal Stromal Cell Therapy FDA Approval for GVHD
December 19, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman makes employee cuts as part of layoff
Layoffs
The 5 Largest Biopharma Layoffs of 2024
December 19, 2024
 · 
7 min read
 · 
Angela Gabriel